NeuroVive Pharmaceutical AB is a world leader in developing cyclosporine-based mitochondrial-protecting pharmaceuticals for the treatment
19 0% Last mo
3 years ago
Use NeuroVive Pharmaceutical's historical employee count to better understand their growth and spending over time.
Unlock with a Free Trial
Use NeuroVive Pharmaceutical's historical monthly uniques as a proxy for mindshare and web traction.
Use NeuroVive Pharmaceutical's historical Linkedin followers to better understand their social media traction over time.
Use NeuroVive Pharmaceutical's mobile downloads and app ranks to evaluate the performance of their mobile apps.
Notice of Extraordinary General Meeting of NeuroVive Pharmaceutical AB (publ)
NeuroVive Decides on a Rights Issue for Continued Drug Development
NeuroVive's KL1333 Program Granted Orphan Drug Designation by the European Commission
NeuroVive Pharmaceutical AB NVP Financial and Strategic SWOT Analysis Review Report Updated 13112017 Prices from USD $300
NeuroVive Presents TBI Clinical Study Results at Nordic Neurotrauma Conference